HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corneal limbal marking in the treatment of myopic astigmatism with the excimer laser.

AbstractPURPOSE:
To determine whether preoperative marking of the limbal cornea improves treatment of myopic astigmatism with the excimer laser.
METHODS:
Retrospective study on 108 eyes with myopic astigmatism that underwent LASIK or laser epithelial keratomileusis (LASEK) with the Technolas 217 (Bausch & Lomb) excimer laser. Preoperative limbal marking was performed in 47 eyes (marked group). The 12-month results were used for refractive and visual analysis.
RESULTS:
The achieved cylinder reduction, spherical reduction, and refractive predictability were similar for the marked and unmarked groups in the overall study collective, in the LASIK and LASEK subgroup analysis, and in a higher astigmatism (> 1.25 diopters) subgroup analysis. Limbal marking showed no influence on the refractive results, and vector analysis showed no significant difference in angle of error among groups.
CONCLUSIONS:
Corneal limbal marking failed to improve the refractive outcome in LASIK and LASEK for myopic astigmatism.
AuthorsCeline Bucher, Bruno Zuberbuhler, Michael Goggin, Adrian Esterman, Isaak Schipper
JournalJournal of refractive surgery (Thorofare, N.J. : 1995) (J Refract Surg) Vol. 26 Issue 7 Pg. 505-11 (Jul 2010) ISSN: 1081-597X [Print] United States
PMID19715268 (Publication Type: Journal Article)
Topics
  • Adult
  • Astigmatism (physiopathology, surgery)
  • Female
  • Humans
  • Keratectomy, Subepithelial, Laser-Assisted
  • Keratomileusis, Laser In Situ
  • Lasers, Excimer (therapeutic use)
  • Limbus Corneae (anatomy & histology)
  • Male
  • Middle Aged
  • Myopia (physiopathology, surgery)
  • Refraction, Ocular (physiology)
  • Retrospective Studies
  • Visual Acuity (physiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: